[Form 4] GitLab Inc. Insider Trading Activity

Rhea-AI Filing Summary

Karen Blasing, a GitLab Inc. director, reported the sale of 3,250 shares of Class A common stock on 08/18/2025 at $45.00 per share. The transaction reduced her beneficial ownership to 103,889 shares, which figure includes unvested Class A shares. The filing notes the sale was executed under a Rule 10b5-1 trading plan established on March 26, 2024, indicating it was prearranged rather than an ad hoc trade. The Form 4 was signed by an attorney-in-fact on behalf of Ms. Blasing on 08/19/2025.

Insights

Corporate Governance Expert

TL;DR: Routine director sale under a 10b5-1 plan, suggesting compliance and reduced signalling risk.

The sale of 3,250 shares at $45 per share was executed pursuant to a 10b5-1 plan dated March 26, 2024. Because the transaction follows a pre-established plan, it reduces the likelihood that the sale was based on undisclosed material information. The remaining reported beneficial ownership of 103,889 shares includes unvested shares, which is relevant when assessing long-term alignment with shareholders.

Securities Analyst

TL;DR: Modest insider disposition; not materially impactful to company valuation.

The reported disposition of 3,250 shares represents a small absolute amount relative to typical public floats and the director's remaining 103,889-share position. The explicit note that some reported shares are unvested is important for accurately gauging current economic interest. The 10b5-1 disclosure and attorney-in-fact signature reflect standard compliance procedures for insiders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BLASING KAREN

(Last) (First) (Middle)

C/O GITLAB INC.

(Street)

NOT APPLICABLE DE

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Gitlab Inc. [ GTLB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/18/2025		S(1)		3,250	D	$45	103,889(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were executed pursuant to a trading plan entered into by the reporting person on March 26, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

2. Includes shares of Class A Common Stock that have not yet vested.

Remarks:

	/s/ Robin Schulman, Attorney-in-Fact for Karen Blasing	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Karen Blasing report selling in the Form 4 for GTLB?

The Form 4 reports the sale of 3,250 shares of Class A common stock on 08/18/2025 at $45.00 per share.

Was the sale by the GitLab director part of a 10b5-1 plan?

Yes. The filing states the sale was executed under a Rule 10b5-1 trading plan entered into on March 26, 2024.

How many GitLab shares does Karen Blasing beneficially own after the reported transaction?

Following the sale, the filing reports beneficial ownership of 103,889 shares, which includes unvested shares.

Who signed the Form 4 for Karen Blasing and when?

The Form 4 was signed by Robin Schulman, Attorney-in-Fact for Karen Blasing on 08/19/2025.